• In its first full quarter since combining with MRC Global, DNOW reported strong revenue growth but weaker profitability, citing ERP transition costs, lower U.S. volumes, and integration efforts that included raising expected 2026 cost synergies to about US$30 million and acquiring Edge Controls to broaden its automation capabilities.
• At the same time, Rosen Law Firm began investigating potential securities claims over allegedly misleading past disclosures, adding a legal overhang just as DNOW seeks to translate merger-driven scale into more efficient, higher-margin operations.
• Next, we’ll examine how DNOW’s raised synergy targets but near-term profitability pressures could reshape the company’s investment narrative post‑merger.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

DNOW Investment Narrative Recap

To own DNOW today, you need to believe the MRC Global merger and ERP rollout can eventually convert higher scale into cleaner earnings and cash flow, despite current losses and integration friction. The most important near term catalyst remains visible progress on profitability, while the biggest risk is that weaker U.S. activity and ongoing disruption from systems changes prolong margin pressure. The Rosen Law Firm investigation adds a legal and reputational overhang, but does not yet appear to alter the operating story in a material way.

Within the recent news, the raised cost synergy target to about US$30 million by 2026 stands out as most relevant. It directly ties to the key catalyst of improving margins, yet sits against a backdrop of ERP transition costs and lower U.S. volumes that are already weighing on results. How quickly DNOW can move from headline revenue growth to more predictable, higher quality earnings will likely shape how investors interpret both the merger and the emerging legal scrutiny.

Yet behind the merger benefits, investors should still be aware of the risk that prolonged weakness in U.S. drilling and completion activity could...

DNOW’s narrative projects $5.5 billion revenue and $179.6 million earnings by 2029. This requires 17.7% yearly revenue growth and a $333.6 million earnings increase from -$154.0 million today.

Uncover how DNOW's forecasts yield a $16.00 fair value, a 21% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community value DNOW in a tight US$16 to about US$19.30 range, showing how closely some private investors are clustering their views. You should weigh those perspectives against the current profitability pressures linked to ERP transition costs and U.S. volume softness, and consider what that might mean for DNOW's ability to translate its larger revenue base into sustainable earnings.

Explore 3 other fair value estimates on DNOW - why the stock might be worth as much as 46% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DNOW research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free DNOW research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DNOW's overall financial health at a glance.

No Opportunity In DNOW?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
• This technology could replace computers: discover 30 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.